Kotra Industries Berhad (KLSE:KOTRA)

Market Cap	593.26M -5.2%
Revenue (ttm)	230.26M -2.3%
Net Income	41.97M +4.9%
EPS	0.28 +4.9%
Shares Out	148.31M
PE Ratio	14.13
Forward PE	12.31
Dividend	0.26 (6.38%)
Ex-Dividend Date	Apr 13, 2026

Volume	24,000
Average Volume	11,955
Open	4.000
Previous Close	4.000
Day's Range	4.000 - 4.000
52-Week Range	3.950 - 4.490
Beta	-0.05
RSI	45.18
Earnings Date	May 22, 2026

About Kotra Industries Berhad

Kotra Industries Berhad, an investment holding company, develops, manufactures, and trades in pharmaceutical and healthcare products in Malaysia. The company provides nutraceutical products, including various health supplement products under the Appeton brand for children, expectant mothers, and senior citizens. It also offers various pharmaceutical products in the areas of pediatric care, anti-infective, gastroenterology, and dermatology under the Axcel brand; sterile antibiotic injectables under the Vaxcel brand; asthma control products under...

• Industry: Pharmaceutical Preparations
• Founded: 1982
• Employees: 635
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: KOTRA

Financial Performance

In fiscal year 2025, Kotra Industries Berhad's revenue was 230.78 million, an increase of 1.87% compared to the previous year's 226.55 million. Earnings were 42.48 million, a decrease of -4.76%.